|
|
|
|
29.07.25 - 14:33
|
SAIC Partners with Xerox to Launch eligibilityNOW to Transform the Speed and Accuracy of Government Benefits Claims Lifecycle (GlobeNewswire EN)
|
|
RESTON, Va., July 29, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced the launch of eligibilityNOW, a commercially-developed, comprehensive claims management solution designed to provide government agencies with secure AI to improve the speed and accuracy for adjudicators in processing user's benefits claims. With Xerox as a technology partner, this rapidly deployable solution addresses the critical issue of eligibility backlogs and delays to provide better outcomes for beneficiaries within a number of government civilian agencies and health departments....
|
|
|
10.07.25 - 00:24
|
XFRA: DIVIDEND/INTEREST INFORMATION - 11.07.2025 - EQUBF_01 (XETRA)
|
|
Das Instrument 85S US8086251076 SCIENCE APPL.INT.CORP.NEW EQUITY wird cum Dividende/Zinsen gehandelt am 10.07.2025 und ex Dividende/Zinsen am 11.07.2025
The instrument 85S US8086251076 SCIENCE APPL.INT.CORP.NEW EQUITY has its pre-dividend/interest day on 10.07.2025 and its ex-dividend/interest day on 11.07.2025...
|
|
|
|
02.06.25 - 13:00
|
SAIC Announces First Quarter of Fiscal Year 2026 Results (GlobeNewswire EN)
|
|
RESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corporation (NASDAQ: SAIC), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, today announced results for the first quarter ended May 2, 2025....
|
|
|
|
30.05.25 - 14:09
|
SAIC Board of Directors Declares Cash Dividend (GlobeNewswire EN)
|
|
RESTON, Va., May 30, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) announced today that the company's board of directors declared a cash dividend of $0.37 per share of the company's common stock payable on July 25, 2025 to stockholders of record on July 11, 2025....
|
|
|
19.05.25 - 14:06
|
Oligo Factory Launches Low-Scale Oligo Synthesis Capability to Broaden Support for Therapeutic and Diagnostic Researchers and Developers (Business Wire)
|
|
Appoints new CEO and VP of Commercial to drive commercial expansion and portfolio strategy
HOLLISTON, Mass.--(BUSINESS WIRE)--#Oligo--Oligo Factory, a leading science-driven provider of high-quality custom DNA and RNA oligonucleotides for therapeutic, diagnostic, and life science applications, today announced the launch of its new low-scale oligo synthesis capability. This expansion enhances the company's ability to broaden support for the development lifecycle of oligo-based therapeutics, including discovery, preclinical and toxicology studies, as well as molecular diagnostic applications. Oligo Factory will showcase its new and comprehensive FactorTx™ for Therapeutics product portfolio, which includes low- and mid-scale oligo synthesis scales, at TIDES USA, taking place May 19–22 in San Diego.
Oligo Factory has also strengthened its leadership team with the appointments of Luke Dannenberg, Ph.D., as Chief Executive Officer, and Baiju Parikh as Vice President of Commercial to drive commercial expans...
|
|
|
|
|
|
09.04.25 - 23:42
|
XFRA: DIVIDEND/INTEREST INFORMATION - 11.04.2025 - US8086251076 (XETRA)
|
|
Das Instrument 85S US8086251076 SCIENCE APPL.INT.CORP.NEW EQUITY wird cum Dividende/Zinsen gehandelt am 10.04.2025 und ex Dividende/Zinsen am 11.04.2025
The instrument 85S US8086251076 SCIENCE APPL.INT.CORP.NEW EQUITY has its pre-dividend/interest day on 10.04.2025 and its ex-dividend/interest day on 11.04.2025...
|
|
|